The following trials provide information to treat various types of respiratory and inflammatory diseases, both for ongoing and completed clinical trials. For more information on both of these therapy areas please click here.
- collapse A Phase 1b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI-545, A Fully Human Anti-Interferon-Alpha Monoclonal Antibody, in Patients with Systemic Lupus Erythematosus
- collapse A Phase 1, Single-Center, Single-Blind, Randomized, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of CAT-354 Following Subcutaneous Administration in Healthy Male and Female Japanese Subjects
- collapse A Prospective Observational Study to Assess the Role of Selected Biomarkers in Subjects Requiring Daily Medium- to High-Dose Inhaled Corticosteroids for Persistent Asthma
- collapse A Phase 2A, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Study to Evaluate the Safety and Tolerability of Multiple Subcutaneous Doses of MEDI-545, A Fully Human Anti-Interferon-Alpha Monoclonal Antibody, in Subjects with Systemic Lupus Erythematosus
- collapse A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Safety and Tolerability of Multiple-Dose Subcutaneous Administration of MEDI-563, a Humanized Anti-Interleukin-5 Receptor Alpha Monoclonal Antibody, in Adults with Asthma
- collapse A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravenously Administered MEDI-563, A Humanized Anti-Interleukin-5 Receptor Alpha Monoclonal Antibody, on Asthma Control Following Acute Exacerbations in Adults
- collapse A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults with Asthma
- collapse A Phase 2b, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous MEDI-528 in Adults with Uncontrolled Asthma
- collapse A Phase 1, Single Ascending Dose Study to Evaluate the Safety of MEDI2338 in Subjects with Chronic Obstructive Pulmonary Disease
- collapse An Exploratory Study of the Cellular Inflammatory Mechanisms Associated with Chronic Obstructive Pulmonary Disease Exacerbations
